Neuland Laboratories Ltd (BOM:524558)
₹ 6561.65 20.45 (0.31%) Market Cap: 84.19 Bil Enterprise Value: 83.94 Bil PE Ratio: 28.06 PB Ratio: 6.56 GF Score: 90/100

Q3 2023 Neuland Laboratories Ltd Earnings Call Transcript

Feb 14, 2023 / 11:00AM GMT
Release Date Price: ₹1591.5 (+12.64%)
Operator

Ladies and gentlemen, good day and welcome to Neuland Laboratories Limited Q3 FY '23 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ravi Udeshi from Ernst & Young. Thank you and over to you.

Ravi Udeshi
Ernst & Young - Analyst

Thank you, Yashashri. Good evening, friends. We welcome you to the Q3 FY '23 earnings call of Neuland Laboratories Limited. To take us through the results and to answer your questions, we have with us the top management from Neuland represented by Mr. Sucheth Davuluri, Vice Chairman and CEO; Mr. Saharsh Davuluri, Vice Chairman and Managing Director; Mr. Abhijit Majumdar, CFO; and Mr. Sajeev Emmanuel Medikonda, Head, Corporate Planning and Strategy.

We will start the call with a brief overview of the financials by Abhijit Majumdar, and then Saharsh will give you a broad highlight of the business trends and what he is observing in the market. And post this, we will open it up for the Q&A session. As usual, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot